Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	74
Overall Study	STARTED	ZPL389 3mg	37
Overall Study	STARTED	ZPL389 10 mg	36
Overall Study	STARTED	ZPL389 30mg	73
Overall Study	STARTED	ZPL389 50mg	73
Overall Study	COMPLETED	Placebo	42
Overall Study	COMPLETED	ZPL389 3mg	16
Overall Study	COMPLETED	ZPL389 10 mg	21
Overall Study	COMPLETED	ZPL389 30mg	39
Overall Study	COMPLETED	ZPL389 50mg	41
Overall Study	NOT COMPLETED	Placebo	32
Overall Study	NOT COMPLETED	ZPL389 3mg	21
Overall Study	NOT COMPLETED	ZPL389 10 mg	15
Overall Study	NOT COMPLETED	ZPL389 30mg	34
Overall Study	NOT COMPLETED	ZPL389 50mg	32

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03517566/flow